The relationship of airway hyperresponsiveness and airway inflammation: Airway hyperresponsiveness in asthma: its measurement and clinical significance.

Airway hyperresponsiveness (AHR) is a clinical feature of asthma and is often in proportion to the underlying severity of the disease. To understand AHR and the mechanisms that contribute to these processes, it is helpful to divide the airway components that affect this feature of asthma into "persistent" and "variable" categories. The persistent component of AHR represents structural changes in the airway, whereas the variable feature relates to inflammatory events. Insight into how these interrelated components of AHR can contribute to asthma is gained by studying treatment effects and models of asthma provocation.

[1]  R. Covar,et al.  Bronchoprovocation testing in asthma. , 2012, Immunology and allergy clinics of North America.

[2]  S. Willsie Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma , 2010 .

[3]  P. O'Byrne,et al.  Provoked models of asthma: what have we learnt? , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[4]  C. Seow,et al.  Structural basis for exaggerated airway narrowing. , 2007, Canadian journal of physiology and pharmacology.

[5]  D. Robinson,et al.  Remodeling and airway hyperresponsiveness but not cellular inflammation persist after allergen challenge in asthma. , 2007, American journal of respiratory and critical care medicine.

[6]  Ben Fabry,et al.  Airway hyperresponsiveness, remodeling, and smooth muscle mass: right answer, wrong reason? , 2007, American journal of respiratory cell and molecular biology.

[7]  D. Cockcroft,et al.  Mechanisms of airway hyperresponsiveness. , 2006, The Journal of allergy and clinical immunology.

[8]  P. Paré Airway hyperresponsiveness in asthma: geometry is not everything! , 2003, American journal of respiratory and critical care medicine.

[9]  K. Chung,et al.  Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsìveness, and the late asthmatic response , 2000, The Lancet.

[10]  P. Gibson,et al.  Airway mast cells and eosinophils correlate with clinical severity and airway hyperresponsiveness in corticosteroid-treated asthma. , 2000, Journal of Allergy and Clinical Immunology.

[11]  J. Vandenbroucke,et al.  Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. , 1999, American journal of respiratory and critical care medicine.

[12]  H. Xu,et al.  Effect of inhaled interleukin-5 on airway hyperreactivity and eosinophilia in asthmatics. , 1998, American journal of respiratory and critical care medicine.

[13]  W. Busse,et al.  Comparison of airway and blood eosinophil function after in vivo antigen challenge. , 1992, Journal of immunology.